Prohormone & Supplement Ingredients:

3,3-azo-17a-methyl-5a-androstan-17b-ol (Methyldiazirinol)

As of 26 March 2013, an apparently new-to-the-street compound. There's still a lot of speculation on this one, and not a whole lot of information. Credit goes to TotalFlexBlog for the following (edited) information.

Methyldiazirinol was first synthesized by researchers at Lederle Laboratories, a subsidiary of American Cyanamid. Their results were reported in 1965. They patented the invention in 1966. Lederle/American Cyanamid also synthesized some 2a-cyano-substituted compounds similar to Cynostane.

Methyldiazirinol was one of many steroids listed in Julius Vida's Androgens and Anabolic Agents. In a section detailing “Compounds displaying decreased androgenic activity coupled with increased anabolic activity”, the 3,3-azo steroid is listed alongside steroids such as oxandrolone (anavar), methenolone (primobolan), stanozolol (winstrol) and norbolethone (one version of “the Clear”).

According to the Lederle Laboratories researchers, the Methyldiazirinol has an oral anabolic:androgenic ratio of 300:20 when compared to methyl testosterone, giving it a "Q factor" of 15. This provides anabolic to androgenic effects similar to the recently-banned methasterone (superdrol), which was reported to have an anabolic:androgenic ratio of 400:20.

Methyldiazirinol was never commercialised, though they continued to explore the possibilities of the diazirine group in other (non-steroidal) molecules. Methyldiazirinol was first released onto the dietary supplement market as Iron Legion Triumphalis (2013).

Street rumble speculates effects similar to that of dymethazine.
Supplements with this ingredient:
Triumphalis (Prohormones)

Links to additional information on 3,3-azo-17a-methyl-5a-androstan-17b-ol (Methyldiazirinol)
Methyldiazirinol (Added on 4/5/2013 5:36:00 AM)

only members can suggest new info links